Press Releases China NT Pharma Group Company Limited

Equities

1011

KYG2114L1133

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-07-02 am EDT			5-day change	1st Jan Change
0.034 ^HKD	-90.29%		-90.68%	-93.82%

Jun. 07	China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation	MT
May. 29	China NT Pharma Group Company Limited Announces Change of Address of the Principal Place of Business and Headquarters	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

China NT Pharma : NOTICE OF BOARD MEETING	22-03-10	PU
China NT Pharma : PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING	21-04-30	PU
China NT Pharma : VOLUNTARY ANNOUNCEMENT SELECTION RESULTS OF NATIONAL CENTRALIZED PHARMACEUTICALS PROCUREMENT	20-08-20	PU
China NT Pharma : SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2019	20-08-16	PU
China NT Pharma : PROFIT WARNING SUPPLEMENTAL ANNOUNCEMENT	20-08-06	PU
China NT Pharma : VOLUNTARY ANNOUNCEMENT SHUSI APPROVED IN CONSISTENCY EVALUATION	20-02-20	PU
China NT Pharma : APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF MEMBER OF BOARD COMMITTEES	19-12-31	PU
China NT Pharma : RESIGNATION OF EXECUTIVE AND NON-EXECUTIVE DIRECTORS AND CHANGE OF CHIEF FINANCIAL OFFICER	19-11-29	PU
China NT Pharma : MONTHLY PROGRESS UPDATE IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION IN RESPECT OF THE ACQUISITION AND SUBSCRIPTION OF SHARES AND CONVERTIBLE BONDS OF HONG KONG WD PHARMACEUTICAL CO., LIMITED (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (3) APPLICATION FOR WHITEWASH WAIVER	19-10-29	PU
China NT Pharma : EXTENSION OF CONDITIONS PRECEDENT LONG STOP DATE AND FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION IN RESPECT OF THE ACQUISITION AND SUBSCRIPTION OF SHARES AND CONVERTIBLE BONDS OF HONG KONG WD PHARMACEUTICAL CO., LIMITED (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (3) APPLICATION FOR WHITEWASH WAIVER	19-09-30	PU
China NT Pharma : FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION IN RESPECT OF THE ACQUISITION AND SUBSCRIPTION OF SHARES AND CONVERTIBLE BONDS OF HONG KONG WD PHARMACEUTICAL CO., LIMITED (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (3) APPLICATION FOR WHITEWASH WAIVER	19-09-06	PU
China NT Pharma : Voluntary Announcement - Increase in Shareholding in the Company by the Controlling Sharehol…	17-05-31	PU
China NT Pharma : PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES AND PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING	17-04-27	PU
China NT Pharma : Change of Name of Principal Share Registrar and Transfer Office in the Cayman Islands	17-04-24	PU
China NT Pharma : Supplemental Agreement in Relation to Proposed Issuance of Convertible Preference Shares	17-04-24	PU
China NT Pharma : (1) Proposed Issue of Convertible Preference Shares (2) Proposed Grant of Specific Mandate t…	17-04-20	PU
China NT Pharma : Annual Results Announcement for the Year ended 31 December 2016	17-03-22	PU
China NT Pharma : VOLUNTARY ANNOUNCEMENT NT BIOPHARMA OBTAINED NEW GMP CERTIFICATION FROM CFDA PRODUCTION AND SALES OF NATIONAL CLASS 1.1 NEW DRUG “XI DI KE” WILL OFFICIALLY COMMENCE	17-03-10	PU
China NT Pharma : Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2017	17-03-10	PU
China NT Pharma : Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2…	17-01-04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases China NT Pharma Group Company Limited

Equities

1011

KYG2114L1133

Press Releases

Filters